Combination of nanoparticles with physical stimuli toward cancer therapy

Biological and Pharmaceutical Bulletin

Volumn 37, Issue 2, 2014, Pages 212-216

  Fumoto, Shintaro ^a   Kawakami, Shigeru ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Drug delivery system; Electroporation; Gene delivery; Hyperthermia; Sonoporation

Indexed keywords

ANTINEOPLASTIC AGENTS; DRUG DELIVERY SYSTEMS; ELECTRIC STIMULATION; HUMANS; NANOPARTICLES; NEOPLASMS; PHYSICAL STIMULATION; ULTRASONOGRAPHY;

EID: 84893281574     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b13-00703     Document Type: Review

References (63)

1. Fumoto S, Kawakami S, Ito Y, Shigeta K, Yamashita F, Hashida M. Enhanced hepatocyte-selective in vivo gene expression by stabilized galactosylated liposome/plasmid DNA complex using sodium chloride for complex formation. Mol. Ther., 10, 719-729 (2004).
2. Yoshikawa N, Sakamoto K, Mizuno S, Sakaguchi J, Miyamoto H, Mine T, Sasaki H, Fumoto S, Nishida K. Multiple components in serum contribute to hepatic transgene expression by lipoplex in mice. J. Gene Med., 13, 632-643 (2011).
3. Fumoto S, Kawakami S, Shigeta K, Higuchi Y, Yamashita F, Hashida M. Interaction with blood components plays a crucial role in asialoglycoprotein receptor-mediated in vivo gene transfer by galactosylated lipoplex. J. Pharmacol. Exp. Ther., 315, 484-493 (2005).
4. Nagayama S, Ogawara K, Minato K, Fukuoka Y, Takakura Y, Hashida M, Higaki K, Kimura T. Fetuin mediates hepatic uptake of negatively charged nanoparticles via scavenger receptor. Int. J. Pharm., 329, 192-198 (2007).
5. Maeda H. Macromolecular therapeutics in cancer treatment: the EPR effect and beyond. J. Control. Release, 164, 138-144 (2012).
6. Hatakeyama H, Akita H, Harashima H. A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemma. Adv. Drug Deliv. Rev., 63, 152-160 (2011).
7. Kawakami S, Fumoto S, Nishikawa M, Yamashita F, Hashida M. In vivo gene delivery to the liver using novel galactosylated cationic liposomes. Pharm. Res., 17, 306-313 (2000).
8. Fumoto S, Nakadori F, Kawakami S, Nishikawa M, Yamashita F, Hashida M. Analysis of hepatic disposition of galactosylated cationic liposome/plasmid DNA complexes in perfused rat liver. Pharm. Res., 20, 1452-1459 (2003).
9. Terada T, Iwai M, Kawakami S, Yamashita F, Hashida M. Novel PEG-matrix metalloproteinase-2 cleavable peptide-lipid containing galactosylated liposomes for hepatocellular carcinoma-selective targeting. J. Control. Release, 111, 333-342 (2006).
10. Hatakeyama H, Akita H, Kogure K, Oishi M, Nagasaki Y, Kihira Y, Ueno M, Kobayashi H, Kikuchi H, Harashima H. Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid. Gene Ther., 14, 68-77 (2007).
11. Manchun S, Dass CR, Sriamornsak P. Targeted therapy for cancer using pH-responsive nanocarrier systems. Life Sci., 90, 381-387 (2012).
12. Frandsen SK, Gissel H, Hojman P, Tramm T, Eriksen J, Gehl J. Direct therapeutic applications of calcium electroporation to effectively induce tumor necrosis. Cancer Res., 72, 1336-1341 (2012).
13. Yao C, Guo F, Li C, Sun C. Gene transfer and drug delivery with electric pulse generators. Curr. Drug Metab., 14, 319-323 (2013).
14. Au JT, Wong J, Mittra A, Carpenter S, Haddad D, Carson J, Jayaraman S, Monette S, Solomon SB, Ezell P, Fong Y. Irreversible electroporation is a surgical ablation technique that enhances gene transfer. Surgery, 150, 474-479 (2011).
15. Lawrie A, Brisken AF, Francis SE, Cumberland DC, Crossman DC, Newman CM. Microbubble-enhanced ultrasound for vascular gene delivery. Gene Ther., 7, 2023-2027 (2000).
16. Suzuki R, Takizawa T, Negishi Y, Hagisawa K, Tanaka K, Sawamura K, Utoguchi N, Nishioka T, Maruyama K. Gene delivery by combination of novel liposomal bubbles with perfluoropropane and ultrasound. J. Control. Release, 117, 130-136 (2007).
17. Ueno Y, Sonoda S, Suzuki R, Yokouchi M, Kawasoe Y, Tachibana K, Maruyama K, Sakamoto T, Komiya S. Combination of ultrasound and bubble liposome enhance the effect of doxorubicin and inhibit murine osteosarcoma growth. Cancer Biol. Ther., 12, 270-277 (2011).
18. Hamano N, Negishi Y, Omata D, Takahashi Y, Manandhar M, Suzuki R, Maruyama K, Nomizu M, Aramaki Y. Bubble liposomes and ultrasound enhance the antitumor effects of AG73 liposomes encapsulating antitumor agents. Mol. Pharm., 10, 774-779 (2013).
19. Negishi Y, Omata D, Iijima H, Takabayashi Y, Suzuki K, Endo Y, Suzuki R, Maruyama K, Nomizu M, Aramaki Y. Enhanced laminin-derived peptide AG73-mediated liposomal gene transfer by bubble liposomes and ultrasound. Mol. Pharm., 7, 217-226 (2010).
20. Un K, Kawakami S, Suzuki R, Maruyama K, Yamashita F, Hashida M. Enhanced transfection efficiency into macrophages and dendritic cells by a combination method using mannosylated lipoplexes and bubble liposomes with ultrasound exposure. Hum. Gene Ther., 21, 65-74 (2010).
21. Un K, Kawakami S, Suzuki R, Maruyama K, Yamashita F, Hashida M. Development of an ultrasound-responsive and mannose-modified gene carrier for DNA vaccine therapy. Biomaterials, 31, 7813-7826 (2010).
22. Un K, Kawakami S, Suzuki R, Maruyama K, Yamashita F, Hashida M. Suppression of melanoma growth and metastasis by DNA vaccination using an ultrasound-responsive and mannose-modified gene carrier. Mol. Pharm., 8, 543-554 (2011).
23. Dickson JA. Hyperthermia in the treatment of cancer. Lancet, 313, 202-205 (1979).
24. Moyer HR, Delman KA. The role of hyperthermia in optimizing tumor response to regional therapy. Int. J. Hyperthermia, 24, 251-261 (2008).
25. Li L, ten Hagen TL, Bolkestein M, Gasselhuber A, Yatvin J, van Rhoon GC, Eggermont AM, Haemmerich D, Koning GA. Improved intratumoral nanoparticle extravasation and penetration by mild hyperthermia. J. Control. Release, 167, 130-137 (2013).
26. Li L, ten Hagen TL, Hossann M, Süss R, van Rhoon GC, Eggermont AM, Haemmerich D, Koning GA. Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy. J. Control. Release, 168, 142-150 (2013).
27. Haar GT, Coussios C. High intensity focused ultrasound: physical principles and devices. Int. J. Hyperthermia, 23, 89-104 (2007).
28. Park SM, Kim MS, Park SJ, Park ES, Choi KS, Kim YS, Kim HR. Novel temperature-triggered liposome with high stability: Formulation, in vitro evaluation, and in vivo study combined with high-intensity focused ultrasound (HIFU). J. Control. Release, 170, 373-379 (2013).
29. Kumar CS, Mohammad F. Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery. Adv. Drug Deliv. Rev., 63, 789-808 (2011).
30. Miyako E, Deguchi T, Nakajima Y, Yudasaka M, Hagihara Y, Horie M, Shichiri M, Higuchi Y, Yamashita F, Hashida M, Shigeri Y, Yoshida Y, Iijima S. Photothermic regulation of gene expression triggered by laser-induced carbon nanohorns. Proc. Natl. Acad. Sci. U.S.A., 109, 7523-7528 (2012).
31. Yang W, Barth RF, Adams DM, Soloway AH. Intratumoral delivery of boronated epidermal growth factor for neutron capture therapy of brain tumors. Cancer Res., 57, 4333-4339 (1997).
32. Pan XQ, Wang H, Shukla S, Sekido M, Adams DM, Tjarks W, Barth RF, Lee RJ. Boron-containing folate receptor-targeted liposomes as potential delivery agents for neutron capture therapy. Bioconj. Chem., 13, 435-442 (2002).
33. Liu F, Huang L. Electric gene transfer to the liver following systemic administration of plasmid DNA. Gene Ther., 9, 1116-1119 (2002).
34. Thanaketpaisarn O, Nishikawa M, Yamashita F, Hashida M. Tissue-specific characteristics of in vivo electric gene: transfer by tissue and intravenous injection of plasmid DNA. Pharm. Res., 22, 883-891 (2005).
35. Chabot S, Rosazza C, Golzio M, Zumbusch A, Teissié J, Rols MP. Nucleic acids electro-transfer: from bench to bedside. Curr. Drug Metab., 14, 300-308 (2013).
36. Suzuki R, Takizawa T, Negishi Y, Utoguchi N, Sawamura K, Tanaka K, Namai E, Oda Y, Matsumura Y, Maruyama K. Tumor specific ultrasound enhanced gene transfer in vivo with novel liposomal bubbles. J. Control. Release, 125, 137-144 (2008).
37. Suzuki R, Namai E, Oda Y, Nishiie N, Otake S, Koshima R, Hirata K, Taira Y, Utoguchi N, Negishi Y, Nakagawa S, Maruyama K. Cancer gene therapy by IL-12 gene delivery using liposomal bubbles and tumoral ultrasound exposure. J. Control. Release, 142, 245-250 (2010).
38. Liu F, Song Y, Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther., 6, 1258-1266 (1999).
39. Zhang G, Budker V, Wolff JA. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum. Gene Ther., 10, 1735-1737 (1999).
40. Mukai H, Kawakami S, Hashida M. Renal press-mediated transfection method for plasmid DNA and siRNA to the kidney. Biochem. Biophys. Res. Commun., 372, 383-387 (2008).
41. Mukai H, Kawakami S, Kamiya Y, Ma F, Takahashi H, Satake K, Terao K, Kotera H, Yamashita F, Hashida M. Pressure-mediated transfection of murine spleen and liver. Hum. Gene Ther., 20, 1157-1167 (2009).
42. Shimizu K, Kawakami S, Hayashi K, Kinoshita H, Kuwahara K, Nakao K, Hashida M, Konishi S. In vivo site-specific transfection of naked plasmid DNA and siRNAs in mice by using a tissue suction device. PLoS ONE, 7, e41319 (2012).
43. Mine T, Ishii H, Nakajima S, Yoshikawa N, Miyamoto H, Nakashima M, Nakamura J, Fumoto S, Nishida K. Rubbing gastric serosal surface enhances naked plasmid DNA transfer in rats and mice. Biol. Pharm. Bull., 34, 1514-1517 (2011).
44. Fumoto S, Nakajima S, Mine T, Yoshikawa N, Kitahara T, Sasaki H, Miyamoto H, Nishida K. Efficient in vivo gene transfer by intraperitoneal injection of plasmid DNA and calcium carbonate microflowers in mice. Mol. Pharm., 9, 1962-1970 (2012).
45. Suzuki T, Shin BC, Fujikura K, Matsuzaki T, Takata K. Direct gene transfer into rat liver cells by in vivo electroporation. FEBS Lett., 425, 436-440 (1998).
46. Shimizu K, Kawakami S, Hayashi K, Mori Y, Hashida M, Konishi S. Implantable pneumatically actuated microsystem for renal pressure-mediated transfection in mice. J. Control. Release, 159, 85-91 (2012).
47. Un K, Kawakami S, Yoshida M, Higuchi Y, Suzuki R, Maruyama K, Yamashita F, Hashida M. The elucidation of gene transferring mechanism by ultrasound-responsive unmodified and mannose-modified lipoplexes. Biomaterials, 32, 4659-4669 (2011).
48. Omata D, Negishi Y, Hagiwara S, Yamamura S, Endo-Takahashi Y, Suzuki R, Maruyama K, Nomizu M, Aramaki Y. Bubble liposomes and ultrasound promoted endosomal escape of TAT-PEG liposomes as gene delivery carriers. Mol. Pharm., 8, 2416-2423 (2011).
49. Nishikawa M, Nakayama A, Takahashi Y, Fukuhara Y, Takakura Y. Reactivation of silenced transgene expression in mouse liver by rapid, large-volume injection of isotonic solution. Hum. Gene Ther., 19, 1009-1020 (2008).
50. Takiguchi N, Takahashi Y, Nishikawa M, Matsui Y, Fukuhara Y, Oushiki D, Kiyose K, Hanaoka K, Nagano T, Takakura Y. Positive correlation between the generation of reactive oxygen species and activation/reactivation of transgene expression after hydrodynamic injections into mice. Pharm. Res., 28, 702-711 (2011).
51. Un K, Kawakami S, Higuchi Y, Suzuki R, Maruyama K, Yamashita F, Hashida M. Involvement of activated transcriptional process in efficient gene transfection using unmodified and mannose-modified bubble lipoplexes with ultrasound exposure. J. Control. Release, 156, 355-363 (2011).
52. Mukai H, Kawakami S, Takahashi H, Satake K, Yamashita F, Hashida M. Key physiological phenomena governing transgene expression based on tissue pressure-mediated transfection in mice. Biol. Pharm. Bull., 33, 1627-1632 (2010).
53. Yamashita Y, Shimada M, Tachibana K, Harimoto N, Tsujita E, Shirabe K, Miyazaki J, Sugimachi K. In vivo gene transfer into muscle via electro-sonoporation. Hum. Gene Ther., 13, 2079-2084 (2002).
54. Yamashita Y, Shimada M, Minagawa R, Tsujita E, Harimoto N, Tanaka S, Shirabe K, Miyazaki J, Maehara Y. Muscle-targeted interleukin-12 gene therapy of orthotopic hepatocellular carcinoma in mice using in vivo electrosonoporation. Mol. Cancer Ther., 3, 1177-1182 (2004).
55. Nakamura J, Fumoto S, Shoji K, Kodama Y, Nishi J, Nakashima M, Sasaki H, Nishida K. Stomach-selective gene transfer following the administration of naked plasmid DNA onto the gastric serosal surface in mice. Biol. Pharm. Bull., 29, 2082-2086 (2006).
56. Nishi J, Fumoto S, Ishii H, Kodama Y, Nakashima M, Sasaki H, Nakamura J, Nishida K. Improved stomach selectivity of gene expression following microinstillation of plasmid DNA onto the gastric serosal surface in mice. Eur. J. Pharm. Biopharm., 69, 633-639 (2008).
57. Fumoto S, Nishi J, Nakamura J, Nishida K. Gene therapy for gastric diseases. Curr. Gene Ther., 8, 187-200 (2008).
58. Fumoto S, Kawakami S, Hashida M, Nishida K. Targeted Gene Delivery: Importance of Administration Routes. NOVEL GENE THERAPY APPROACHES (Wei M, Good D eds.) Intech, Croatia, pp. 3-31 (2013).
59. Fumoto S, Nishi J, Ishii H, Wang X, Miyamoto H, Yoshikawa N, Nakashima M, Nakamura J, Nishida K. Rac-mediated macropinocytosis is a critical route for naked plasmid DNA transfer in mice. Mol. Pharm., 6, 1170-1179 (2009).
60. Sakai M, Nishikawa M, Thanaketpaisarn O, Yamashita F, Hashida M. Hepatocyte-targeted gene transfer by combination of vascularly delivered plasmid DNA and in vivo electroporation. Gene Ther., 12, 607-616 (2005).
61. Kishida T, Asada H, Satoh E, Tanaka S, Shinya M, Hirai H, Iwai M, Tahara H, Imanishi J, Mazda O. In vivo electroporation-mediated transfer of interleukin-12 and interleukin-18 genes induces significant antitumor effects against melanoma in mice. Gene Ther., 8, 1234-1240 (2001).
62. Wells JM, Li LH, Sen A, Jahreis GP, Hui SW. Electroporation-enhanced gene delivery in mammary tumors. Gene Ther., 7, 541-547 (2000).
63. Un K, Kawakami S, Yoshida M, Higuchi Y, Suzuki R, Maruyama K, Yamashita F, Hashida M. Efficient suppression of murine intracellular adhesion molecule-1 using ultrasound-responsive and mannose-modified lipoplexes inhibits acute hepatic inflammation. Hepatology, 56, 259-269 (2012).